Analyst consensus rating
IceCure Medical Analyst Rating: Strong Buy
ICCM is rated Strong Buy by 3 analysts with a $22.67 target. As of 2026-08-27.
Direct answer
IceCure Medical's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $22.67.
Forecast evidence checked August 27, 2026.
Get free IceCure Medical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.29
- Average price target
- $22.67
- High price target
- $30.00
- Low price target
- $10.00
- Low target gap
- +336.7%
- Target upside
- +889.8%
- High target gap
- +1,210%
- Target range width
- 873.4%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for IceCure Medical?
IceCure Medical has a verified Strong Buy consensus. The same dataset has an average price target of $22.67.
How far are IceCure Medical's low and high targets from the recorded price?
The low target implies +336.7%, while the high target implies +1,210%.
How many analysts are included in IceCure Medical's consensus?
The verified consensus includes 3 analysts.
How is IceCure Medical's target upside or downside calculated?
The average target of $22.67 is divided by the recorded price of $2.29, then one is subtracted to produce +889.8%. This does not guarantee a future return.
When was IceCure Medical's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.